Evidence map›Paper›PMID 38333968›Full record

ArticleChemistryOpen2024

Electrochemical detection of miRNA using commercial and hand-made screen-printed electrodes: liquid biopsy for cancer management as case of study.

Ada Raucci, Wanda Cimmino, Sabrina Romanò, Sima Singh, Nicola Normanno, Federico Polo, Stefano Cinti

Open access · goldAbstract read
In one paragraph

Article in ChemistryOpen, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ada RaucciDepartment of Pharmacy, University of Naples Federico II, Via Domenico Montesano 9, 80131, Naples, Italy.
Wanda CimminoDepartment of Pharmacy, University of Naples Federico II, Via Domenico Montesano 9, 80131, Naples, Italy.
Sabrina RomanòDepartment of Pharmacy, University of Naples Federico II, Via Domenico Montesano 9, 80131, Naples, Italy.
Sima SinghDepartment of Pharmacy, University of Naples Federico II, Via Domenico Montesano 9, 80131, Naples, Italy.
Nicola NormannoCell Biology and Biotherapy Unit, Istituto Nazionale Tumori (IRCCS) Fondazione Pascale, Via Mariano Semmola 53, 80131, Naples, Italy.
Federico PoloDepartment of Molecular Sciences and Nanosystems, Ca' Foscari University of Venice, Via Torino 155, 30172, Venice, Italy.
Stefano CintiDepartment of Pharmacy, University of Naples Federico II, Via Domenico Montesano 9, 80131, Naples, Italy.ORCID 0000-0002-8274-7452
Federico II University Hospital · ITCa' Foscari University of Venice · ITIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · IT

Funding

AIRC MFAG 2022 - ID. 27586
6 · The paper itself

Abstract

The growth of liquid biopsy, i. e., the possibility of obtaining health information by analysing circulating species (nucleic acids, cells, proteins, and vesicles) in peripheric biofluids, is pushing the field of sensors and biosensors beyond the limit to provide decentralised solutions for nonspecialists. In particular, among all the circulating species that can be adopted in managing cancer evolution, both for diagnostic and prognostic applications, microRNAs have been highly studied and detected. The development of electrochemical devices is particularly relevant for liquid biopsy purposes, and the screen-printed electrodes (SPEs) represent one of the building blocks for producing novel portable devices. In this work, we have taken miR-2115-3p as model target (it is related to lung cancer), and we have developed a biosensor by exploiting the use of a complementary DNA probe modified with methylene blue as redox mediator. In particular, the chosen sensing architecture was applied to serum measurements of the selected miRNA, obtaining a detection limit within the low nanomolar range; in addition, various platforms were interrogated, namely commercial and hand-made SPEs, with the aim of providing the reader with some insights about the optimal platform to be used by considering both the cost and the analytical performance.

Indexed as

Biosensing TechniquesElectrochemical TechniquesElectrodesMicroRNAsHumansLimit of DetectionLiquid BiopsyLung NeoplasmsMethylene BlueNeoplasmsMethylene BlueMicroRNAsElectroanalysisLiquid biopsymiRNAPaper-basedScreen-printed electrodes

Identifiers

PMID38333968
PMCPMC11230927
OpenAlexW4391684364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.